Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. SPY
3. EL
4. BILL
5. MRK
6. MRNA
7. ADI
8. LOW
9. TJX
10. DE

Go back to Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 45.33 -1.63 (3.47%)
Previous Close $46.96    52 Week High $4.38 
Open $46.24    52 Week Low $1.88 
Day High $47.34    P/E N/A 
Day Low $44.80    EPS $-1.12 
Volume 66,123